Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLPsy: Liraglutide Effects on Brain Metabolism and Cognition
NCT06818292Completed
- Start
- Oct 2024
- Primary completion
- Dec 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of liraglutide in obesity and type 2 diabetes mellitus (T2DM). Primary endpoint: Neuropsychology: Processing speed at 1 week. Started Oct 2024; status: completed.
02
Drugs
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06818292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06818292.